RICHMOND, Calif., July 07, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that the company plans to participate in Cantor Fitzgerald’s 2nd Annual Healthcare Conference in New York City.
Ekso Bionics’ management is scheduled to present on Wednesday, July 13th at 11:45am ET. Interested parties can access the live audio webcast with accompanying slides on the investors section of the company’s website at www.eksobionics.com. The webcast replay will be available following the conclusion of the presentation.
About Ekso Bionics
Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical, industrial and defense applications. Founded in 2005, the company continues to build upon its unparalleled expertise to design some of the most cutting-edge, innovative wearable robots available on the market. They are the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe, to providing research for the advancement of R&D projects intended to benefit U.S. defense capabilities. The company is headquartered in the Bay Area and is listed on the OTCQB under the symbol (OTCQB:EKSO). For more information, visit: www.eksobionics.com.